ICCT

iCoreConnect Inc. [ICCT] Stock Forecast

Q: What is iCoreConnect Inc. stock symbol ?

iCoreConnect Inc. is a US stock, located in Ocoee of Fl and trading under the symbol ICCT

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

ICCT Stock Summary

Earnings have grown 61.16% per last year.

In the last year, shareholders have seen their holdings diluted. Dilution over past year is 38.53%

Earnings are expected to fall -100% next year

EPS has been decreasing for the past 3 quarters (Quarter statements)

Does not have any significance market cap ($13.29M)

Profit margins (-1.35%) are lower than the previous year (-0.92%)

ICCT has less than 1 year of cash runway

Top 10 Correlated Stocks

ICCT

In the News

ICCT Financial details

Company Rating

Neutral

Market Cap

13.29M

Income

-10.45M

Revenue

7.75M

Book val./share

0.88

Cash/share

0.06

Dividend

Dividend %

Employees

Optionable

Shortable

Yes

Earnings

21 Mar 2024

P/E

-0.9

Forward P/E

PEG

-0.26

P/S

1.5

P/B

1.47

P/C

19.83

P/FCF

-5.5

Quick Ratio

0.12

Current Ratio

0.22

Debt / Equity

0.77

LT Debt / Equity

0.16

EPS (TTM)

-1.59

EPS next Y

EPS next Q

EPS this Y

8.47%

EPS next Y

EPS next 5Y

EPS last 5Y

-23.2%

Revenue last 5Y

48.96%

Revenue Q/Q

8.01%

EPS Q/Q

24.39%

SMA20

-1.53%

SMA50

-20.37%

SMA100

-4.44%

Inst Own

Inst Trans

ROA

-64%

ROE

1424%

ROC

-1%

Gross Margin

75%

Oper. Margin

-96%

Profit Margin

-135%

Payout

Shs Outstand

Shs Float

Target Price

52W Range

0.93-10.6

52W High

52W Low

RSI

45.67

Rel Volume

0.14

Avg Volume

435.46K

Volume

62.36K

Perf Week

5.31%

Perf Month

-13.14%

Perf Quarter

-37.37%

Perf Half Y

-49.79%

Beta

291.345

Volatility

0.17%, 0.13%

Prev Close

-0.83%

Price

1.19

Change

-2.46%

ICCT Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	0.73	0.52	0.83	1.01	1.38
Net income per share	-4.79	-1.61	-1.44	-1.18	-1.28
Operating cash flow per share	-1.32	-0.85	-0.5	-0.59	-0.22
Free cash flow per share	-1.55	-1.07	-0.71	-0.65	-0.27
Cash per share	0	0.23	0	0.01	0.03
Book value per share	-0.64	0.24	-0.25	0.2	-0.43
Tangible book value per share	-1.64	-0.74	-1.18	-0.9	-1.2
Share holders equity per share	-0.64	0.24	-0.25	0.2	-0.43
Interest debt per share	1.44	0.6	0.71	0.91	1.3
Market cap	13.39K	52.7M	7.64M	16.18M	15.34M
Enterprise value	1.93M	53.2M	9.21M	20.07M	21.85M
P/E ratio	0	-16.7	-2.07	-2.79	-2.09
Price to sales ratio	0.01	51.97	3.6	3.26	1.92
POCF ratio	-0.01	-31.61	-6.01	-5.59	-12.05
PFCF ratio	-0.01	-25.22	-4.21	-5.06	-9.79
P/B Ratio	-0.01	113.33	-12.14	16.09	-6.13
PTB ratio	-0.01	113.33	-12.14	16.09	-6.13
EV to sales	1.77	52.47	4.34	4.05	2.74
Enterprise value over EBITDA	-0.42	-19.08	-3.86	-6.62	-5.46
EV to operating cash flow	-0.98	-31.92	-7.25	-6.93	-17.17
EV to free cash flow	-0.83	-25.46	-5.08	-6.28	-13.95
Earnings yield	-535.01	-0.06	-0.48	-0.36	-0.48
Free cash flow yield	-172.64	-0.04	-0.24	-0.2	-0.1
Debt to equity	-2	2.04	-2.51	3.94	-2.68
Debt to assets	1.1	0.38	0.59	0.6	1.02
Net debt to EBITDA	-0.42	-0.18	-0.66	-1.28	-1.63
Current ratio	0.09	0.29	0.05	0.25	0.16
Interest coverage	-13.87	-14.32	-13.56	-6.56	-6.11
Income quality	0.38	0.56	0.36	0.58	0.21
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	3.17	3.35	1.59	0.99	1.09
Research and developement to revenue	0	0.62	0	0	0
Intangibles to total assets	0.86	0.76	0.89	0.82	0.68
Capex to operating cash flow	0.17	0.25	0.43	0.1	0.23
Capex to revenue	-0.31	-0.42	-0.26	-0.06	-0.04
Capex to depreciation	-0.84	-0.65	-0.6	-0.21	-0.23
Stock based compensation to revenue	2.61	0.6	0.2	0.07	0.21
Graham number	8.31	2.93	2.82	2.33	3.53
ROIC	-4.65	-2.44	-3.1	-0.76	-1.12
Return on tangible assets	-29.23	-5.15	-11.98	-4.82	-3.49
Graham Net	-1.69	-0.78	-1.26	-1.03	-1.48
Working capital	-2.29M	-1.38M	-3.03M	-3.04M	-5.71M
Tangible asset value	-2.45M	-1.44M	-3.01M	-4.42M	-6.95M
Net current asset value	-2.46M	-1.5M	-3.17M	-4.61M	-7.97M
Invested capital	-2	2.04	-2.51	3.94	-2.68
Average receivables	0	162.5K	113.74K	377.76K	521.93K
Average payables	0	-57M	1.33M	1.65M	1.99M
Average inventory	0	0	0	0	0
Days sales outstanding	75.08	36.36	21.74	46.32	18.95
Days payables outstanding	-93.49K	1.2K	602.08	379.17	380.12
Days of inventory on hand	0	0	0	0	0
Receivables turnover	4.86	10.04	16.79	7.88	19.26
Payables turnover	0	0.3	0.61	0.96	0.96
Inventory turnover	0	0	0	0	0
ROE	7.48	-6.78	5.85	-5.77	2.94
Capex per share	-0.23	-0.22	-0.21	-0.06	-0.05

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric	2022-09-30	2022-12-31	2023-03-31	2023-06-30	2023-09-30
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	0.33	0.35	0.29	0.28	0.28
Net income per share	-0.3	-0.31	-0.36	-0.41	-0.51
Operating cash flow per share	-0.04	0.07	-0.18	-0.12	0.02
Free cash flow per share	-0.05	0.05	-0.21	-0.17	0
Cash per share	0.03	0.03	0.13	0.01	0.06
Book value per share	-0.33	-0.43	-0.41	-0.64	0.88
Tangible book value per share	-1.13	-1.2	-1.08	-1.29	0.11
Share holders equity per share	-0.33	-0.43	-0.41	-0.64	0.88
Interest debt per share	1.19	1.2	1.2	1.23	0.75
Market cap	18.95M	15.39M	21.94M	29.09M	28.9M
Enterprise value	25.43M	21.9M	28.54M	36.83M	33.38M
P/E ratio	-2.73	-2.17	-2.4	-2.69	-1.96
Price to sales ratio	10.03	7.53	11.92	15.67	14.41
POCF ratio	-78.72	38.21	-19.04	-37.91	183.26
PFCF ratio	-60.78	49.68	-16.29	-26.18	855.91
P/B Ratio	-9.9	-6.15	-8.4	-6.88	4.51
PTB ratio	-9.9	-6.15	-8.4	-6.88	4.51
EV to sales	13.46	10.71	15.51	19.84	16.65
Enterprise value over EBITDA	-28.29	-19.33	-24.99	-17.17	-13.49
EV to operating cash flow	-105.63	54.38	-24.77	-47.99	211.69
EV to free cash flow	-81.56	70.71	-21.2	-33.14	988.72
Earnings yield	-0.09	-0.12	-0.1	-0.09	-0.13
Free cash flow yield	-0.02	0.02	-0.06	-0.04	0
Debt to equity	-3.47	-2.68	-2.84	-1.85	0.77
Debt to assets	0.98	1.02	1.06	1.22	0.3
Net debt to EBITDA	-7.21	-5.75	-5.78	-3.6	-1.81
Current ratio	0.16	0.16	0.23	0.11	0.22
Interest coverage	-4.93	-6.81	-5.24	-7.79	-5.06
Income quality	0.17	-0.24	0.68	0.28	-0.04
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	1.09	1.29	1.24	1.62	1.73
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.69	0.68	0.62	0.66	0.34
Capex to operating cash flow	0.3	-0.23	0.17	0.45	-0.79
Capex to revenue	-0.04	-0.05	-0.11	-0.19	-0.06
Capex to depreciation	-0.25	-0.32	-0.67	-1.18	-0.39
Stock based compensation to revenue	0.14	0.46	0.15	0.4	0.2
Graham number	1.5	1.73	1.81	2.44	3.18
ROIC	-0.23	-0.32	-0.32	-0.52	-0.22
Return on tangible assets	-0.83	-0.84	-0.85	-1.25	-0.34
Graham Net	-1.41	-1.48	-1.34	-1.57	-1.25
Working capital	-5.31M	-5.71M	-5.72M	-8.76M	-6.98M
Tangible asset value	-6.56M	-6.95M	-6.93M	-8.46M	779.06K
Net current asset value	-7.63M	-7.97M	-7.94M	-9.52M	-7.98M
Invested capital	-3.47	-2.68	-2.84	-1.85	0.77
Average receivables	603.5K	459.97K	378.59K	354.16K	481.8K
Average payables	1.84M	2.17M	-1.43M	-1.23M	3.85M
Average inventory	1	0.5	0	0	0
Days sales outstanding	24.07	18.26	16.74	17.74	26.83
Days payables outstanding	348.47	447.28	-951.6	510.58	859.88
Days of inventory on hand	0	0	0	0	0
Receivables turnover	3.74	4.93	5.38	5.07	3.35
Payables turnover	0.26	0.2	-0.09	0.18	0.1
Inventory turnover	517.66K	0	0	0	0
ROE	0.91	0.71	0.87	0.64	-0.58
Capex per share	-0.01	-0.02	-0.03	-0.05	-0.02

ICCT Frequently Asked Questions

What is iCoreConnect Inc. stock symbol ?

iCoreConnect Inc. is a US stock , located in Ocoee of Fl and trading under the symbol ICCT

What is iCoreConnect Inc. stock quote today ?

iCoreConnect Inc. stock price is $1.19 today.

Is iCoreConnect Inc. stock public?

Yes, iCoreConnect Inc. is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 435.46K
Market Capitalization 13.29M
Employee 41
CEO Mr. Robert P. McDermott
Headquarters Ocoee,FL,US
IPO Date 2023-09-05
Website https://www.icoreconnect.com

iCoreConnect Inc., a cloud-based software and technology company, provides cloud-based software products for the healthcare sector in the United States. The company's products include iCoreRx, a compliant electronic prescription software; iCoreExchange, a software as a service (SaaS) email solution that allows doctors to send and receive secure email with attachments to and from other healthcare professionals, patients, and referrals; iCoreCodeGenius that provides the coding standards for the 10th revision of the international classification of diseases and related health problems; and iCoreVerify, a compliant SaaS solution that allows practices to verify patient insurance benefits automatically and on-demand. Its products also comprise iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; iCoreCloud, a compliant and automated backup solution, which offers customers to back up their on-premise servers and computers to the cloud; iCorePay, a patient payment processing solutions for payment and revenue cycle tracking; iCoreSecure, an encrypted email to protect personal and financial data; and iCoreIT, an IT managed services. The company was formerly known as iMedicor, Inc. and changed its name to iCoreConnect Inc. in June 2017. iCoreConnect Inc. was founded in 1992 and is headquartered in Ocoee, Florida.